MedPath

Prochlorperazine Edisylate

Rx only

Approved
Approval ID

f793cdb3-9fd8-79e1-e053-6394a90ae08b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 4, 2023

Manufacturers
FDA

FOSUN PHARMA USA INC

DUNS: 080920998

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Prochlorperazine Edisylate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72266-204
Application NumberANDA214107
Product Classification
M
Marketing Category
C73584
G
Generic Name
Prochlorperazine Edisylate
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 4, 2023
FDA Product Classification

INGREDIENTS (6)

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Quantity: 5 mg in 1 mL
Code: 593YOG76RN
Classification: IACT
SACCHARIN SODIUMInactive
Quantity: 0.9 mg in 1 mL
Code: SB8ZUX40TY
Classification: IACT
SODIUM TARTRATE DIHYDRATEInactive
Quantity: 12 mg in 1 mL
Code: DIA7C37AOW
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 7.5 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
PROCHLORPERAZINE EDISYLATEActive
Quantity: 5 mg in 1 mL
Code: PG20W5VQZS
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Prochlorperazine Edisylate - FDA Drug Approval Details